Treatment of bacterial keratitis in mouse using Ag nanoparticles suspension
Journal of Biomaterials Applications · 2026
DOI: 10.1177/08853282261456461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2026. Verfasst von Chang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Silver, Keratitis, Anti-Bacterial Agents, Metal Nanoparticles. Die Arbeit nennt 45 Literaturangaben. Gefördert von: The Natural Science Foundation of Tibet Autonomous Region, Key Research and Development Technology project of Anhui Province, The College Students’ Innovation and Entrepreneurship Training Project of Anhui Province.
Abstract (Originalsprache)
This study aimed to develop a novel topical treatment for Pseudomonas aeruginosa ( P. aeruginosa )-induced bacterial keratitis (BK) using silver nanoparticles (Ag NPs), addressing critical limitations of current antibiotics, such as poor ocular penetration and microbial resistance. Ag NPs were synthesized via silver-cysteine conjugation and characterized by UV-Vis spectroscopy, zeta potential, dynamic light scattering (DLS), TEM, XRD, and XPS. In vitro, the nanoparticles exhibited potent antibacterial activity against P. aeruginosa with minimal cytotoxicity toward human corneal epithelial cells (HCECs). Notably, they also retained observable activity against methicillin-resistant Staphylococcus aureus (MRSA), suggesting potential for addressing drug-resistant infections. In a mouse model of P. aeruginosa -induced bacterial keratitis, topical application of the Ag NPs effectively ameliorated the infection without harming healthy ocular tissues, demonstrating favorable biocompatibility and strong therapeutic potential. Overall, Ag NPs represent a promising topical nanotherapeutic for BK, offering enhanced ocular bioavailability, retained activity against drug-resistant strains, and favorable biocompatibility, highlighting their strong potential for clinical translation in ocular infection management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China.
- Department of Ophthalmology, Shannan People's Hospital of Tibet, Shannan, China.
ORCID-Profile: Dongwei Liu
Förderung
- The Natural Science Foundation of Tibet Autonomous Region
- Key Research and Development Technology project of Anhui Province
- The College Students’ Innovation and Entrepreneurship Training Project of Anhui Province
- The Natural Science Foundation for Group-style Medical Aid Project of Tibet Autonomous Region
Zitieren
APA
Liu, C., Wei, Z., Wang, L., Zhang, Q., & Liu, D. (2026). Treatment of bacterial keratitis in mouse using Ag nanoparticles suspension. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282261456461
Vancouver
Liu C, Wei Z, Wang L, Zhang Q, Liu D. Treatment of bacterial keratitis in mouse using Ag nanoparticles suspension. Journal of Biomaterials Applications. 2026. doi:10.1177/08853282261456461
BibTeX
@article{Liu2026,
author = {Liu, Chang and Wei, Zhezhen and Wang, Lanlan and Zhang, Qing and Liu, Dongwei},
title = {Treatment of bacterial keratitis in mouse using Ag nanoparticles suspension},
journal = {Journal of Biomaterials Applications},
year = {2026},
doi = {10.1177/08853282261456461}
}
EUVIMED